uOttawa medical scientist leads pioneering cancer immunotherapy research with $3M grant (IMAGE)
Caption
“We believe that only by looking at a patient as a whole – from the brain to the gut to the immune cells in our blood – we can truly personalize therapy to maximize success,” says Dr. Michele Ardolino, Professor in the University of Ottawa Faculty of Medicine’s Department of Biochemistry, Microbiology and Immunology and Senior Scientist in cancer research at The Ottawa Hospital’s Research Institute.
Credit
Faculty of Medicine, University of Ottawa
Usage Restrictions
None
License
Original content